CHIESI FARMACEUTICI S.p.A. Headquarters, Parma, ItalyParma, Emilia-Romagna, Italy
Disclosure information not submitted.
SUN-666 - Effectiveness and Safety of Metreleptin Therapy in Patients with Partial Lipodystrophy: A Systematic Review
Sunday, June 14, 20269:00 AM - 4:00 PM CT